21 implants across four countries
PRIME study participants in the US, UK, Canada and UAE; no serious device-related adverse events reported.
A device reads brain signals and turns them into commands: a person with paralysed hands moves a cursor or speaks words without moving.
The human-machine bandwidth is the bottleneck nobody talks about. If the machine thinks faster, the channel becomes the limit.
PRIME study participants in the US, UK, Canada and UAE; no serious device-related adverse events reported.
The programme moved from isolated cases to continuous enrolment.
Speech decoding, arm control and vision hold FDA breakthrough designations.
Neuralink implants into the cortex, Synchron threads a stent through a vein with no craniotomy, Precision lays a film on the surface. The argument is about acceptable risk, not signal quality.
Every programme runs under investigational status. No paralysis implant holds full regulatory approval.
Today this is medicine for severe conditions. Mass use requires safety that justifies the risk for a healthy person.
A channel wider than a keyboard — today a human passes about ten bits per second to a machine.